Orlistat Teva (Orlistat)

Orlistat works by binding irreversibly to gastric and pancreatic lipases in the gastrointestinal tract. This inhibition prevents the enzymatic breakdown of dietary triglycerides, reducing fat absorption by about 30 % and allowing the unabsorbed fat to be excreted, thereby lowering overall caloric intake.

The prescribed dose of Orlistat Teva is determined by the treating clinician based on the patient’s weight, dietary plan, and therapeutic goals. Typically, the medication is taken with each main meal containing fat, but the exact regimen should follow the prescriber’s instructions.

Orlistat is not recommended for use during pregnancy or while breastfeeding because its safety profile has not been established for these populations. Women who are pregnant, planning to become pregnant, or nursing should discuss alternative weight‑management strategies with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Orlistat Teva. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and import documentation.

Unlike appetite‑suppressing agents, Orlistat works peripherally by blocking dietary fat absorption rather than affecting central nervous system pathways. This mechanism results in a distinct side‑effect profile, primarily gastrointestinal, and makes it suitable for patients who prefer a non‑systemic approach to weight management.

Orlistat Teva should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains sealed until use to maintain product stability.

Orlistat Teva is taken orally with each main meal that contains fat, usually as a single tablet per meal. If a meal is missed or contains no fat, the dose may be omitted. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks, though rare, include acute liver injury, severe abdominal pain, pancreatitis, and allergic reactions such as rash or swelling. Patients should seek immediate medical attention if they experience any of these symptoms while using Orlistat.

Orlistat Teva is contraindicated in individuals with chronic malabsorption syndrome, cholestasis, or known hypersensitivity to the drug. It should also be avoided by pregnant or breastfeeding women and by patients taking medications that require consistent fat absorption without appropriate monitoring.